Subtopic Deep Dive

ABC Transporters in Cancer Chemotherapy
Research Guide

What is ABC Transporters in Cancer Chemotherapy?

ABC transporters are ATP-binding cassette proteins that efflux chemotherapeutic agents from cancer cells, conferring multidrug resistance in chemotherapy.

Beyond P-glycoprotein (ABCB1), ABCC1-12 subfamily transporters export diverse drugs in solid tumors and leukemias (Dean et al., 2001; 1732 citations). Their overexpression reduces intracellular drug accumulation, limiting treatment efficacy (Leonard et al., 2003; 817 citations). Over 10,000 papers document their roles since 2001.

15
Curated Papers
3
Key Challenges

Why It Matters

ABC transporters drive resistance to anthracyclines, taxanes, and vinca alkaloids in breast cancer, leukemia, and lung tumors, reducing 5-year survival rates by 20-30% (Bukowski et al., 2020; 1646 citations). Targeting ABCC1 with inhibitors restores drug sensitivity in preclinical models (Giacomini et al., 2010; 3272 citations). Personalized therapies inhibiting specific ABC isoforms enable precision chemotherapy reversal.

Key Research Challenges

Substrate Specificity Overlap

ABCC1-12 share overlapping substrates like cisplatin and etoposide, complicating selective inhibition (Shen et al., 2012; 945 citations). Genetic polymorphisms alter transport efficiency across tumors (Dean et al., 2001). Distinguishing isoform contributions requires isoform-specific assays.

Tissue-Specific Expression

ABCB1 dominates in brain tumors via blood-brain barrier, while ABCC2 prevails in liver cancers (Pardridge, 2004; 2611 citations; Löscher and Potschka, 2004; 836 citations). Variable expression patterns hinder universal inhibitors. Tumor microenvironment regulates expression dynamically.

Regulatory Pathway Crosstalk

PI3K/AKT signaling upregulates ABC transporters, linking resistance to growth pathways (Liu et al., 2020; 865 citations). Epigenetic changes amplify expression in cisplatin-resistant cells (Shen et al., 2012). Multi-target inhibitors must address pathway integration.

Essential Papers

1.

Membrane transporters in drug development

Kathleen M. Giacomini, Shiew‐Mei Huang, Donald Tweedie et al. · 2010 · Nature Reviews Drug Discovery · 3.3K citations

2.

The blood-brain barrier: Bottleneck in brain drug development

William M. Pardridge · 2004 · NeuroRx · 2.6K citations

3.

The Human ATP-Binding Cassette (ABC) Transporter Superfamily

Michael Dean, Andrey Rzhetsky, Rando Allikmets · 2001 · Genome Research · 1.7K citations

The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes. Genetic variation in these gen...

4.

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski, Mateusz Kciuk, Renata Kontek · 2020 · International Journal of Molecular Sciences · 1.6K citations

Cancer is one of the main causes of death worldwide. Despite the significant development of methods of cancer healing during the past decades, chemotherapy still remains the main method for cancer ...

5.

Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

Ding‐Wu Shen, Lynn M. Pouliot, Matthew D. Hall et al. · 2012 · Pharmacological Reviews · 945 citations

6.

Bile Acid Signaling in Metabolic Disease and Drug Therapy

Tiangang Li, John Y.L. Chiang · 2014 · Pharmacological Reviews · 873 citations

7.

PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers

Rui Liu, Youwen Chen, Guangzhi Liu et al. · 2020 · Cell Death and Disease · 865 citations

Abstract Multidrug resistance (MDR) is the dominant challenge in the failure of chemotherapy in cancers. Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that spreads intracellular signal cas...

Reading Guide

Foundational Papers

Start with Dean et al. (2001; 1732 citations) for ABC superfamily structure, then Giacomini et al. (2010; 3272 citations) for drug interactions, followed by Leonard et al. (2003; 817 citations) for clinical roles.

Recent Advances

Bukowski et al. (2020; 1646 citations) updates mechanisms; Liu et al. (2020; 865 citations) links PI3K/AKT pathways.

Core Methods

Efflux assays with calcein-AM for ABCC1 activity; ATPase assays measure transport kinetics; CRISPR knockout validates resistance contributions.

How PapersFlow Helps You Research ABC Transporters in Cancer Chemotherapy

Discover & Search

Research Agent uses searchPapers('ABC transporters multidrug resistance cancer') to retrieve 5,000+ papers, then citationGraph on Giacomini et al. (2010; 3272 citations) maps high-impact clusters on ABCC subfamily roles. findSimilarPapers expands to isoform-specific studies; exaSearch uncovers unpublished preprints on ABCC1 inhibitors.

Analyze & Verify

Analysis Agent applies readPaperContent to extract transporter expression data from Bukowski et al. (2020), then runPythonAnalysis with pandas to quantify resistance correlations across 20 tumor types. verifyResponse (CoVe) with GRADE grading scores claims on PI3K/ABC crosstalk (Liu et al., 2020) for evidence strength, enabling statistical verification of fold-resistance metrics.

Synthesize & Write

Synthesis Agent detects gaps in ABCC2-targeting therapies post-2020 via contradiction flagging against Leonard et al. (2003), generating exportMermaid diagrams of transporter networks. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations to integrate 50 references, and latexCompile for camera-ready reviews on resistance reversal strategies.

Use Cases

"Correlate ABCC1 expression levels with doxorubicin IC50 in breast cancer cell lines from 10 papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on IC50 data) → CSV export of regression plots showing 3.5-fold resistance correlation.

"Write LaTeX review section on ABCC transporters in leukemia resistance with citations"

Research Agent → citationGraph('Dean 2001') → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → PDF with 25 integrated references and resistance mechanism figure.

"Find GitHub code for ABC transporter simulation models from recent papers"

Research Agent → paperExtractUrls('ABC transporter modeling') → Code Discovery → paperFindGithubRepo → githubRepoInspect → Verified PK/PD simulation code for ABCC1 efflux kinetics.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(ABC cancer) → 50+ papers → DeepScan (7-step verification with CoVe checkpoints on Giacomini 2010 claims) → structured report on isoform inhibitors. Theorizer generates hypotheses linking PI3K/AKT (Liu et al., 2020) to ABCC regulation, validated via runPythonAnalysis. DeepScan analyzes Bukowski et al. (2020) for resistance mechanisms with GRADE scoring.

Frequently Asked Questions

What defines ABC transporters in cancer chemotherapy?

ATP-powered efflux pumps from the ABC superfamily, including ABCC1-12, export chemotherapeutics like doxorubicin and cisplatin from cancer cells (Dean et al., 2001).

What are key methods to study ABC transporter resistance?

qPCR/Western blots quantify expression; flow cytometry measures efflux with fluorescent substrates; siRNA knockdown confirms functional roles (Leonard et al., 2003).

What are seminal papers on ABC transporters?

Dean et al. (2001; 1732 citations) catalogs the superfamily; Giacomini et al. (2010; 3272 citations) details drug development impacts; Bukowski et al. (2020; 1646 citations) reviews mechanisms.

What open problems exist in ABC targeting?

Isoform-selective inhibitors fail clinically due to compensatory upregulation; no approved ABCC1 blockers exist despite preclinical promise (Leonard et al., 2003).

Research Drug Transport and Resistance Mechanisms with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching ABC Transporters in Cancer Chemotherapy with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers